Status:
UNKNOWN
Validation of Two New Questionnaires for Dupuytren's Disease
Lead Sponsor:
Robert Hotchkiss
Collaborating Sponsors:
Auxilium Pharmaceuticals, Inc.
Conditions:
Dupuytren's Disease
Eligibility:
All Genders
35+ years
Brief Summary
A study to validate two newly developed questionnaires for Dupuytren's Disease. The objective is to develop a patient specific outcomes tool for Dupuytren's Disease. While there are standard and valid...
Eligibility Criteria
Inclusion
- Subject has a diagnosis of Dupuytren's Disease in at least one finger
- Patients will be 35 years of age or older
- Patients will be able to read, speak, and understand English
- Patients will be able to provide voluntary written consent to participate
Exclusion
- Female patients who are nursing or pregnant, or plan to become pregnant during the treatment phase.
- Patient has a chronic muscular, neurological or neuromuscular disorder that affects the hands.
- Patient has a known allergy to collagenase or any other excipient of XIAFLEX.
- Patient has received any collagenase treatments before the first dose of XIAFLEX.
- Any history of or current medical condition which in the investigator's opinion would make the subject unsuitable for enrollment in the study
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01446432
Start Date
February 1 2011
End Date
December 1 2015
Last Update
April 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital For Special Surgery
New York, New York, United States, 10021